Reported Dec 28, 2022 · Ongoing
Glycopyrrolate Tablets, USP, 1 mg, 100 tablets, Rx Only, Distributed by: Aurobindo Pharma USA, Inc., East Windsor, NJ…
Aurolife Pharma, LLC
Moderate riskThis product could cause temporary or reversible health problems — stop using it.What you should do
Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.
Firm contact: Aurolife Pharma, LLC · 2400 US Highway 130 · Dayton, NJ · 08810-1519
Is this the product you have?
- Glycopyrrolate Tablets, USP, 1 mg, 100 tablets, Rx Only
- Distributed byAurobindo Pharma USA, Inc., East Windsor, NJ 08520, NDC 13107-014-01
- Lot codes and dates
- Lots01422002A1
- Expiry
12/202301421078A3
- Expiry09/2023
- Amount recalled
- 7344 bottles
Where it was sold
- Nationwide
- PR
Why it was recalled
Failed Impurities/Degradation Specifications
This product could cause temporary or reversible health problems — stop using it.
Want the full recall guide?
The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.
Free recall alerts
Get alerted about new Aurolife Pharma, LLC recalls
One email when a matching recall is published. No account, no cost, unsubscribe in one click.
We email you about recalls and nothing else. Every send has a one-click unsubscribe, and you can change your preferences any time without an account.